Oculir Raises $7.3M Series A

San Diego-based Oculir said yesterday that it has raised $7.3M in a Series A investment from Onset Ventures, CHL Medical Partners, Canaan Partners, Three Arch Partners, Shepherd VEntures, and Windamere Venture Partners. The firm is developing a commercial, non-invasive glucuse testing system for people with diabetes. The company's technology is based on measuring the white of the eye to determine glucose levels. Oculir said that the funding will be used to continue development of the company's device and performing expanded human clinical trials. More information »